Manuel Alba sold $6.1M of ALAB
director at Astera Labs, Inc.. 100,000 shares at an average of $60.94, traded Apr 2, 2025, filed Apr 4, 2025.
Score components
- +15RoleDirector
- +25Trade size$6.1M at market
- +5Share of holdings soldSold 22% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001736297-25-000024, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -200 | $59.86 | $12k | 456,663 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -600 | $61.79 | $37k | 456,063 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -3,001 | $62.37 | $187k | 453,062 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -5,162 | $63.68 | $329k | 447,900 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -2,937 | $64.26 | $189k | 444,963 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -100 | $65.14 | $6,514 | 444,863 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -600 | $59.91 | $36k | 2,063,898 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -2,100 | $61.68 | $130k | 2,061,798 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -12,779 | $62.34 | $797k | 2,049,019 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -19,654 | $63.62 | $1.3M | 2,029,365 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -14,867 | $64.18 | $954k | 2,014,498 | Apr 4, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -1,000 | $65.09 | $65k | 2,013,498 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -4,036 | $55.97 | $226k | 440,827 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -1,963 | $56.97 | $112k | 438,864 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -1,401 | $58.01 | $81k | 437,463 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -600 | $58.89 | $35k | 436,863 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -14,137 | $55.95 | $791k | 1,999,361 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -6,526 | $56.87 | $371k | 1,992,835 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -5,337 | $57.88 | $309k | 1,987,498 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -2,900 | $58.67 | $170k | 1,984,598 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -100 | $59.54 | $5,954 | 1,984,498 | Apr 4, 2025 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $4.7M 12,499 shares | -25% | |
| 33Weak | Astera Labs, Inc. | Manuel Alba director | $51M 183,000 shares | -14% | |
| 33Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.4M 12,499 shares | -23% | |
| 17Weak | Astera Labs, Inc. | Bethany Mayer director | $60k 686 shares | -10% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $2.0M 20,150 shares | -5% | |
| 45Moderate | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $5.3M 52,743 shares | -1% | |
| 40Moderate | Astera Labs, Inc. | Sanjay Gajendra President and COO | $7.5M 76,373 shares | -1% | |
| 45Moderate | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $10M 106,510 shares | -2% | |
| 40Moderate | Astera Labs, Inc. | Sanjay Gajendra President and COO | $8.7M 88,627 shares | -1% | |
| 52Moderate | Astera Labs, Inc. | Michael Truett Tate Chief Financial Officer | $45M 500,000 shares | -45% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.